Tuesday, January 26, 2016

14 Lies That Our Psychiatry Professors in Medical School Taught Us


Dr. Gary Kohls
Myth # 1:

“The FDA (US Food and Drug Administration) tests all new psychiatric drugs”

False. Actually the FDA only reviews studies that were designed, administered, secretly performed and paid for by the multinational profit-driven drug companies. The studies are frequently farmed out by the pharmaceutical companies by well-paid research firms, in whose interest it is to find positive results for their corporate employers. Unsurprisingly, such research policies virtually guarantee fraudulent results.
Myth # 2:

“FDA approval means that a psychotropic drug is effective long-term”

False. Actually, FDA approval doesn’t even mean that psychiatric drugs have been proven to be safe – either short-term or long-term! The notion that FDA approval means that a psych drug has been proven to be effective is also a false one, for most such drugs are never tested – prior to marketing – for longer than a few months (and most psych patients take their drugs for years). The pharmaceutical industry pays many psychiatric “researchers” – often academic psychiatrists (with east access to compliant, chronic, already drugged-up patients) who have financial or professional conflicts of interest – some of them even sitting on FDA advisory committees who attempt to “fast track” psych drugs through the approval process. For each new drug application, the FDA only receives 1 or 2 of the “best” studies (out of many) that purport to show short-term effectiveness. The negative studies are shelved and not revealed to the FDA. In the case of the SSRI drugs, animal lab studies typically lasted only hours, days or weeks and the human clinical studies only lasted, on average, 4- 6 weeks, far too short to draw any valid conclusions about long-term effectiveness or safety!

Hence the FDA, prescribing physicians and patient-victims should not have been “surprised” by the resulting epidemic of SSRI drug-induced adverse reactions that are silently plaguing the nation. Indeed, many SSRI trials have shown that those drugs are barely more effective than placebo (albeit statistically significant!) with unaffordable economic costs and serious health risks, some of which are life-threatening and known to be capable of causing brain damage.
Myth # 3:

 “FDA approval means that a psychotropic drug is safe long-term”

False. Actually, the SSRIs and the “anti-psychotic” drugs are usually tested in human trials for only a couple of months before being granted marketing approval by the FDA. And the drug companies are only required to report 1 or 2 studies (even if many other studies on the same drug showed negative, even disastrous,  results). Drug companies obviously prefer that the black box and fine print warnings associated with their drugs are ignored by both consumers and prescribers. One only has to note how small the print is on the commercials.

In our fast-paced shop-until-you-drop consumer society, we super-busy prescribing physicians and physician assistants have never been fully aware of the multitude of dangerous, potentially fatal adverse psych drug effects that include addiction, mania, psychosis, suicidality, worsening depression, worsening anxiety, insomnia, akathisia, brain damage, dementia, homicidality, violence, etc, etc.
But when was the last time anybody heard the FDA or Big Pharma apologize for the damage they did in the past? And when was the last time there were significant punishments (other than writs slaps and “chump change” multimillion dollar fines) or prison time for the CEOs of the guilty multibillion dollar drug companies?  (Continue Reading)

Full Article & Source:
14 Lies That Our Psychiatry Professors in Medical School Taught Us

1 comment:

  1. I heard Dr. Kohls speak on Marti Oakley's show a while back and he really impressed me. Thank you for the article.

    ReplyDelete